Matt Hale, international sales & marketing director, HRS Heat Exchangers, explains the importance of evaporation in maintaining the characteristics of CBD oil as opposed to traditional extraction processes.
Decision makers from European pharma and biotech companies will hear from two speakers at Connect in Pharma, Jean-François Hilaire (Recipharm) and Christian Wölbeling (Körber Pharma Software), on how to ensure a strong future in European pharma.
Natasha Rivas, vice president of quality and regulatory, and Jose Cruz, director of vector manufacturing at Genezen, explore the difficulties in ensuring cGMP compliance is achieved throughout viral vector production.
A new report sets out 20 key recommendations which, upon implementation, would set the UK on a path to become the global leader in cannabinoid innovation.
Lisa Owens and Jerry Temko, managing directors, In-House Counsel Practice - Major, Lindsey & Africa, share the challenges of recruiting pharma talent in a post-Brexit climate.
Datwyler, a manufacturer of elastomer components for pharmaceutical packaging, is expanding its portfolio with two new products to meet evolving patient demands.
Ribbon Biolabs, the DNA synthesis company, announced that the U.S. Patent and Trademark Office has issued U.S. Patent US 11352619 B2, covering Ribbon Biolabs’ novel method for synthesising DNA, using a diverse library of oligonucleotides.
Rebekah Jordan caught up with Cindy Reiss-Clark, chief commercial officer of West, at the recent Pharmapack show, to talk about its latest innovations and progress through the pandemic.
Lonza's Conrad Roten and David Lyon explain why integrated drug substance and drug product services can help shorten First-In-Human (FIH) trial and drug commercialisation timelines.
Vertellus shares insight on Hollow Fibre Membranes (HFM) in biopharmaceuticals and how it became a crucial part of the biotech industry’s value chain in recent years.
